Machine-Learning-Based Classification Model to Address Diagnostic Challenges in Transbronchial Lung Biopsy

Background: When obtaining specimens from pulmonary nodules in TBLB, distinguishing between benign samples and mis-sampling from a tumor presents a challenge. Our objective is to develop a machine-learning-based classifier for TBLB specimens. Methods: Three pathologists assessed six pathological fin...

Full description

Bibliographic Details
Main Authors: Hisao Sano, Ethan N. Okoshi, Yuri Tachibana, Tomonori Tanaka, Kris Lami, Wataru Uegami, Yoshio Ohta, Luka Brcic, Andrey Bychkov, Junya Fukuoka
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/16/4/731
_version_ 1797298703681191936
author Hisao Sano
Ethan N. Okoshi
Yuri Tachibana
Tomonori Tanaka
Kris Lami
Wataru Uegami
Yoshio Ohta
Luka Brcic
Andrey Bychkov
Junya Fukuoka
author_facet Hisao Sano
Ethan N. Okoshi
Yuri Tachibana
Tomonori Tanaka
Kris Lami
Wataru Uegami
Yoshio Ohta
Luka Brcic
Andrey Bychkov
Junya Fukuoka
author_sort Hisao Sano
collection DOAJ
description Background: When obtaining specimens from pulmonary nodules in TBLB, distinguishing between benign samples and mis-sampling from a tumor presents a challenge. Our objective is to develop a machine-learning-based classifier for TBLB specimens. Methods: Three pathologists assessed six pathological findings, including interface bronchitis/bronchiolitis (IB/B), plasma cell infiltration (PLC), eosinophil infiltration (Eo), lymphoid aggregation (Ly), fibroelastosis (FE), and organizing pneumonia (OP), as potential histologic markers to distinguish between benign and malignant conditions. A total of 251 TBLB cases with defined benign and malignant outcomes based on clinical follow-up were collected and a gradient-boosted decision-tree-based machine learning model (XGBoost) was trained and tested on randomly split training and test sets. Results: Five pathological changes showed independent, mild-to-moderate associations (AUC ranging from 0.58 to 0.75) with benign conditions, with IB/B being the strongest predictor. On the other hand, FE emerged to be the sole indicator of malignant conditions with a mild association (AUC = 0.66). Our model was trained on 200 cases and tested on 51 cases, achieving an AUC of 0.78 for the binary classification of benign vs. malignant on the test set. Conclusion: The machine-learning model developed has the potential to distinguish between benign and malignant conditions in TBLB samples excluding the presence or absence of tumor cells, thereby improving diagnostic accuracy and reducing the burden of repeated sampling procedures for patients.
first_indexed 2024-03-07T22:38:48Z
format Article
id doaj.art-91950c92eb05432ba2cd184a156a9679
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-07T22:38:48Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-91950c92eb05432ba2cd184a156a96792024-02-23T15:10:43ZengMDPI AGCancers2072-66942024-02-0116473110.3390/cancers16040731Machine-Learning-Based Classification Model to Address Diagnostic Challenges in Transbronchial Lung BiopsyHisao Sano0Ethan N. Okoshi1Yuri Tachibana2Tomonori Tanaka3Kris Lami4Wataru Uegami5Yoshio Ohta6Luka Brcic7Andrey Bychkov8Junya Fukuoka9Department of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Nagasaki, JapanDepartment of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Nagasaki, JapanDepartment of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Nagasaki, JapanDepartment of Diagnostic Pathology, Izumi City General Hospital, Izumi 594-0073, Osaka, JapanDepartment of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Nagasaki, JapanDepartment of Pathology, Kameda Medical Center, Kamogawa 296-8602, Chiba, JapanDepartment of Diagnostic Pathology, Izumi City General Hospital, Izumi 594-0073, Osaka, JapanDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, AustriaDepartment of Pathology, Kameda Medical Center, Kamogawa 296-8602, Chiba, JapanDepartment of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Nagasaki, JapanBackground: When obtaining specimens from pulmonary nodules in TBLB, distinguishing between benign samples and mis-sampling from a tumor presents a challenge. Our objective is to develop a machine-learning-based classifier for TBLB specimens. Methods: Three pathologists assessed six pathological findings, including interface bronchitis/bronchiolitis (IB/B), plasma cell infiltration (PLC), eosinophil infiltration (Eo), lymphoid aggregation (Ly), fibroelastosis (FE), and organizing pneumonia (OP), as potential histologic markers to distinguish between benign and malignant conditions. A total of 251 TBLB cases with defined benign and malignant outcomes based on clinical follow-up were collected and a gradient-boosted decision-tree-based machine learning model (XGBoost) was trained and tested on randomly split training and test sets. Results: Five pathological changes showed independent, mild-to-moderate associations (AUC ranging from 0.58 to 0.75) with benign conditions, with IB/B being the strongest predictor. On the other hand, FE emerged to be the sole indicator of malignant conditions with a mild association (AUC = 0.66). Our model was trained on 200 cases and tested on 51 cases, achieving an AUC of 0.78 for the binary classification of benign vs. malignant on the test set. Conclusion: The machine-learning model developed has the potential to distinguish between benign and malignant conditions in TBLB samples excluding the presence or absence of tumor cells, thereby improving diagnostic accuracy and reducing the burden of repeated sampling procedures for patients.https://www.mdpi.com/2072-6694/16/4/731transbronchial lung biopsy (TBLB)non-diagnostic samplesDelphi methodinterface bronchitis/bronchiolitis (IB/B)decision-tree based classifiers
spellingShingle Hisao Sano
Ethan N. Okoshi
Yuri Tachibana
Tomonori Tanaka
Kris Lami
Wataru Uegami
Yoshio Ohta
Luka Brcic
Andrey Bychkov
Junya Fukuoka
Machine-Learning-Based Classification Model to Address Diagnostic Challenges in Transbronchial Lung Biopsy
Cancers
transbronchial lung biopsy (TBLB)
non-diagnostic samples
Delphi method
interface bronchitis/bronchiolitis (IB/B)
decision-tree based classifiers
title Machine-Learning-Based Classification Model to Address Diagnostic Challenges in Transbronchial Lung Biopsy
title_full Machine-Learning-Based Classification Model to Address Diagnostic Challenges in Transbronchial Lung Biopsy
title_fullStr Machine-Learning-Based Classification Model to Address Diagnostic Challenges in Transbronchial Lung Biopsy
title_full_unstemmed Machine-Learning-Based Classification Model to Address Diagnostic Challenges in Transbronchial Lung Biopsy
title_short Machine-Learning-Based Classification Model to Address Diagnostic Challenges in Transbronchial Lung Biopsy
title_sort machine learning based classification model to address diagnostic challenges in transbronchial lung biopsy
topic transbronchial lung biopsy (TBLB)
non-diagnostic samples
Delphi method
interface bronchitis/bronchiolitis (IB/B)
decision-tree based classifiers
url https://www.mdpi.com/2072-6694/16/4/731
work_keys_str_mv AT hisaosano machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy
AT ethannokoshi machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy
AT yuritachibana machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy
AT tomonoritanaka machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy
AT krislami machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy
AT wataruuegami machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy
AT yoshioohta machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy
AT lukabrcic machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy
AT andreybychkov machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy
AT junyafukuoka machinelearningbasedclassificationmodeltoaddressdiagnosticchallengesintransbronchiallungbiopsy